HR Execs on the Move

Cutera

www.cutera.com

 
Cutera was established in the San Francisco Bay Area (Brisbane) in 1998 by veteran laser and optical engineers. As the pioneer of Nd:YAG technology, CUTERA® is the trusted authority in Face + Body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. At Cutera, we`re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. CUTERA`s premium portfolio of products include: xeo®, truSculpt® and excel V™. In 2014, CUTERA introduced two new exciting additions to their family of premium ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.cutera.com
  • 3240 Bayshore Boulevard
    Brisbane, CA USA 94005
  • Phone: 415.657.5500

Executives

Name Title Contact Details
Stuart Drummond
 Interim Chief Financial Officer Profile
Roycie Eppler
 Chief Human Resources Officer Profile
Lukas Hunziker
 Senior Vice President, Research and Development Profile

Similar Companies

Orametrix

Orametrix is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tri-therapy Inc

Tri-therapy Inc is a Searcy, AR-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

shl

shl is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Access Point Technologies

Access Point Technologies is a Rogers, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accelerate Diagnostics

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The companys revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.